Company Filing History:
Years Active: 2009-2012
Title: Innovations of Vikas Prabhakar in Chondroitinase ABC I
Introduction
Vikas Prabhakar is a notable inventor based in Cambridge, MA (US). He has made significant contributions to the field of biochemistry, particularly in the development of chondroitinase ABC I. With a total of five patents to his name, Prabhakar's work has the potential to impact various therapeutic applications.
Latest Patents
Prabhakar's latest patents focus on chondroitinase ABC I and its methods of degradation. The inventions relate to recombinant and modified chondroitinase ABC I, detailing their production and diverse uses. These enzymes are instrumental in degrading and analyzing polysaccharides, including glycosaminoglycans (GAGs) such as chondroitin sulfate, dermatan sulfate, unsulfated chondroitin, and hyaluronan. Furthermore, the chondroitinase ABC I enzymes can be utilized in therapeutic methods aimed at promoting nerve regeneration, aiding stroke recovery, treating spinal cord injuries, addressing epithelial diseases, combating infections, and even treating cancer.
Career Highlights
Vikas Prabhakar is affiliated with the Massachusetts Institute of Technology, where he continues to advance his research and innovations. His work is characterized by a commitment to exploring the therapeutic potentials of biochemistry and enzyme technology.
Collaborations
Prabhakar collaborates with talented individuals such as Ishan Capila and Rahul Raman, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Vikas Prabhakar's contributions to the field of biochemistry, particularly through his patents on chondroitinase ABC I, highlight his role as a leading inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic applications.